Making sense of Big Data - Challenges and Opportunities with NLP
The recent pandemic has shown that despite the incredible amount of available data, we are still unable to turn it into actionable insights. After discussing the current costs of not exploiting this information, I will describe a series of recent works where Natural Language Processing and, more in general, Artificial Intelligence techniques have been utilized to optimize clinical processes, drug development and adverse events monitoring.
Enrico Santus is a senior data scientist at Bayer. After his PhD at the Hong Kong Polytechnic University, Enrico joined the group of Regina Barzilay at CSAIL, MIT. His academic career includes affiliations with the King's College of London, the University of Pisa, the University of Stuttgart, the Nara Institute of Technology and Harvard. His work touches topics such as NLP in Oncology, Cardiology and Palliative Care. Enrico has also worked on Epidemiology, Fake News Detection, Sentiment Analysis and Lexical Semantics. As of today, Enrico has published over 50 papers, with over 637 citations. He collaborated to the creation of The Prayer (artist: Diemut Strebe), a mouth-shaped robot that pronounces original prayers, generated with Artificial Intelligence, exposed at the Centre Pompidou, in Paris. He was also involved in the creation of Safe Paths, the MIT tracing app.